Diverse molecular methods have shown that, in a large majority of human breast carcinomas, HER-2 protein overexpression occurs as a consequence of an alteration in proto-oncogene expression (amplification) that transforms the gene into an oncogene [2,3]. The gene discussed is ERBB2; the disease is breast carcinoma.